These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7888067)

  • 1. Complement in human diseases: looking towards the 21st century.
    Pascual M; French LE
    Immunol Today; 1995 Feb; 16(2):58-61. PubMed ID: 7888067
    [No Abstract]   [Full Text] [Related]  

  • 2. Intervention in the complement system: a therapeutic strategy in inflammation.
    Morgan BP
    Biochem Soc Trans; 1996 Feb; 24(1):224-9. PubMed ID: 8674670
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical considerations in clinical cardiac xenografting.
    Pierson RN; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement and complement inhibitors: their role in autoimmune and inflammatory diseases.
    Sheerin NS; Sacks SH
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):305-10. PubMed ID: 9617562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [General comments on complement].
    Belisario A; Modiano A; Cipolla C; D'Antuono G
    G Clin Med; 1980 Mar; 61(3):169-76. PubMed ID: 7390090
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of complement and complement regulatory proteins in glomerulonephritis.
    Quigg RJ
    Springer Semin Immunopathol; 2003 May; 24(4):395-410. PubMed ID: 12778335
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement proteins and complement inhibitors in Alzheimer's disease.
    McGeer PL; McGeer EG
    Res Immunol; 1992; 143(6):621-4. PubMed ID: 1455053
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1994 Jun; 26(3):1256-8. PubMed ID: 7518124
    [No Abstract]   [Full Text] [Related]  

  • 10. New approach to prevent complement activation on xenografts: effects of a surface-bound form of human C4b binding protein.
    Mikata S; Miyagawa S; Kamiike W; Ito T; Matsuda H; Iwata K; Nagasawa S; Seya T; Shirakura R
    Transplant Proc; 1998 Feb; 30(1):65-6. PubMed ID: 9474958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of complement inactivator gene for control of heterograft rejection].
    Takeshita K; Arakawa K; Akioka S; Fujiwara I; Okamoto M; Akami T; Oka T
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):675-8. PubMed ID: 8963781
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complement system: biological functions].
    Santaella ML
    Bol Asoc Med P R; 1981 May; 73(5):209-15. PubMed ID: 7034739
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of combined expression of human complement regulatory proteins and H-transferase on the inhibition of complement-mediated cytolysis in porcine embryonic fibroblasts.
    Lee JH; Lee HJ; Nahm KM; Jeon HY; Hwang WS; Paik NW; Rho HM
    Transplant Proc; 2006 Jun; 38(5):1618-21. PubMed ID: 16797369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 16. The possible role of membrane complement regulators in vasculitis.
    Daha MR
    Behring Inst Mitt; 1993 Aug; (92):184-90. PubMed ID: 7504449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.
    Hayashi S; Isobe K; Emi N; Okada H; Yasutomi M; Negita M; Koike C; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Feb; 27(1):330. PubMed ID: 7533402
    [No Abstract]   [Full Text] [Related]  

  • 19. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.